Table 2.
A few “dominant” clonotypes produce most of the circulating abs in pemphigus patients
| Patient identifier | # of total clones | # of dominanta clones | % of dominant clones | % of total ab production per clone | |
|---|---|---|---|---|---|
| dominant clones | non-dominant clones | ||||
| PV1a | 22 | 3 | 14 | 19 | 2 |
| PV8 | 37 | 3 | 8 | 17 | 1 |
| PV16 | 30 | 6 | 20 | 9 | 2 |
| PV3 | 34 | 5 | 15 | 10 | 2 |
| PV3a | 56 | 4 | 7 | 13 | 1 |
| PF1 | 18 | 1 | 6 | 52 | 3 |
| PF1a | 23 | 3 | 13 | 18 | 2 |
| PF4 | 63 | 7 | 11 | 7 | 1 |
| PF4a | 55 | 3 | 5 | 19 | 1 |
| PF4b | 52 | 7 | 13 | 7 | 1 |
| Mean ± SEM | 11 ± 1b | 17 ± 4 | 2 ± 0c | ||
Dominant clones are defined as the highest producing circulating ab clonotypes that together produce more than 50% of the total abs in any patient
p<0.0005 compared to 50% using one-sample test of proportion
p=0.005 for % of total ab per clone dominant compared to non-dominant by Wilcoxon signed-rank test